Prof. Dr. Ulrich Keilholz

About

About Prof. Dr. Ulrich Keilholz Prof. Dr. Ulrich Keilholz is a Berlin-based Medical Oncologist with more than 27 years in the field. He is a Member of the American Society for Clinical Oncology (ASCO), the Deutsche Gesellschaft für Hematology/Oncology (DGHO), Arbeitsgemeinschaft Internistische Oncology (AIO). He was the Vice President (2002-2004) and President (2004-2006) of the International Society for Biological Therapy of Cancer (iSBTc). He is also on the ESMO Faculty (Principles of Clinical Trials and Systemic Therapy, Melanoma, Tumour Immunology & Immunotherapy), and Annals of Oncology Editorial Board member (2011-2014). He completed studying medicine at the Universities of Mainz, Heidelberg, Lexington, KY, the USA in 1977, and later pursued a doctoral degree at the Institute of Pathophysiology and Sports Medicine, University of Heidelberg/Germany in 1984. Prof. Keilholz has a wide experience with investigational therapies and has published in several scientific journals such as Lancet, J Clin Oncology, Blood, Leukemia, Cancer Research, Clinical Cancer Research, etc. He has been actively involved in nearly 20 clinical phase I, II, and III trials covering diseases in medical oncology and haematology, with focus on sarcoma, melanoma, lymphomas, carcinomas of the stomach, ovary, lung, colon, and kidney.